We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Magmanus thought he was on the SYME board
Magmanus
What are you talking about?
You been on the pop early? Lols
some excellent fact based posts here...all comming out.
1.2-2p in range. if digi can ....syme defo can. (in a day)...but no bother can wait to end fo the week etc.
IPO price was about 1.2p, that shoudl be default number now. period.
£10k buy this morning
Just wait till they confirm the report findings this will re-rate significantly.
For someone who recently just joined lse and starts dripping negative narrative on this BB, one wonders what their aim is?
Peeps wanting to buy read BELOW:
Approval only to SYMPHONY. Effective only for Symphony and does not include any other or similar products made by other companies. DYOR.
The approval, which is not time limited, has been given under the Food Contact Notification procedure and is effective only for Symphony and does not include any other or similar products made by other companies.
"This approval therefore provides Symphony with a new and immediate commercial opportunity in the western world's largest market, as well as in other markets which expect to see FDA approval," the company said.
Thank you for your reply. I'm trying to establish a factual & balance view, so counter points are very welcome.
According to this website the FCN process is quite quick. But the 120 days won't include gathering the testing data.
https://www.smithers.com/resources/2016/apr/fcn-system-quickest-route-to-regulatory-approval
'The FCN process is also relatively quick. Once the notification has been submitted to the FDA, it has 120 days to accept or reject the submission. If this deadline is not met, the product is automatically considered legal.'
I take the point about FDA approval being a plus / recognised outside the US.
Detailed post but I think you’re trying to say it can be easily done by others...well it took SYM like 10yrs to get FDA approval! So whoever wants to mimic it can go ahead and spend another decade getting FDA approval.
You also appear to undermine FDA approval, yes it’s US only approval but like the company have mentioned many non-EU countries like Middle East, Asia, South American countries all accept US approvals over their own so this opened a hugh market place for SYM.
So, the 'dragon's den' questions are...
The recent results for killing coronavirus on a surface including d2p is good news for sure, but does this give SYM advantage in the market? What evidence and approvals might be needed?
Is the use of zinc pyrithione to treat materials unique to SYM? A google reveals masks on the market treated with silver (antibacterial) and also with zinc pyrithione. So treatment of materials / fabric isn't unique to SYM. So, given that the active ingredient is known, not produced by SYM, and is widely available, what is to prevent any other business doing what they've done? Unique technology or IP would be best, though not vital if they have first mover advantage, or it is cheaper for their customers to buy d2p vs. make their own?
Regarding the bread packaging end use, it certainly it could be cheaper, easier and quicker to buy a product with FDA approval than go to the time and cost of doing it. Finally, the EU. FDA approval is a USA thing only. In the EU you can use the zinc compound. If used to protected a product against mould etc, then there aren't any big barriers from an EU regulations perspective. However, if active isn't there to protect the product itself (but to kill something external to the product), then the product may need registration in the EU. Not a problem, but it does take time and money.
Finally, a note on SYM's other technology - oxy biodegradable plastics. Do they have any IP here? The way this works is well know, you can read all about it on Wikipedia.
This is here (from the British Plastics Federation) isn't very positive...
https://www.bpf.co.uk/press/biodegradable-and-oxo-biodegradable-plastics.aspx
"Based on the evidence, the BPF believes Biodegradable and oxodegradable plastics are concepts that may resonate with some of the general public but they do not provide a viable solution to reducing the amount of plastic that wrongly ends up in the natural environment. These materials do not currently fully break down in the marine environment and could even cause harm during this process."
From <https://www.bpf.co.uk/press/biodegradable-and-oxo-biodegradable-plastics.aspx>
Anyone have anything to add?
Thanks for reading.
I've been doing some research into the d2p products. Comments welcome, as I could have missed something.
SYM has a series of product under the brand d2p. The one of recent interest is plastic with an additive that has antibacterial, anti-mould and, according to the recent independent lab report, antivirus properties.
Antimicrobial product:
https://www.symphonyenvironmental.com/wp-content/uploads/2020/07/Antimircobial-Optimised-1.pdf
This product sheet mentions the FDA approval for bread (though there is another one dedicated to that too). Searching around on the FDA site, I found an approval for SYM, for the antimould bread packaging. The active ingredient is Zinc pyrithione. A commonly used antimould (used in paints to help prevent mould growing on the wall in damp bathroom, for example. It is also used in anti dandruff shampoo).
Is the bread application unique to SYM? From the FDA website..
"According to Section 409(h)(1)(C) of the Federal Food, Drug, and Cosmetic Act, food contact substance notifications (FCNs) are effective only for the listed manufacturer and its customers. Other manufacturers must submit their own FCN for the same food contact substance and intended use."
https://www.accessdata.fda.gov/scripts/fdcc/?set=FCN&id=2031&sort=FCN_No&order=DESC&startrow=1&type=basic&search=Bread
So, it looks like other companies could potentially apply for and receive the same authorisation, for bread or other food applications.
Anti-viral too?
From the RNS.."Symphony Environmental Technologies Plc (AIM: SYM), is pleased to announce positive antiviral test results from Eurofins Laboratories for its d2p antimicrobial masterbatch technology."
So, it is the antimicrobial product that was tested and found to work on bovine coronavirus. So zinc pyrithione is the magic ingredient (probably...). Has anyone else found this compound to work on a virus? Yes. E.g. https://pubmed.ncbi.nlm.nih.gov/21079686/
So, the 'dragon's den' questions are... in part 2 of this note